Combination of SN-38 with gefitinib or imatinib overcomes SN-38-resistant small-cell lung cancer cells
Nagio Takigawa(Kawasaki Medical School), Kiyoshi Takahashi(National Cancer Center Hospital East)
Cited by 15
Related Papers
Immunohistochemical study on the distribution of α and β subunits of S-100 protein in human neoplasm and normal tissues
|Virchows Archiv B Cell Pathology Including Molecular Pathology|1984|283